Drug Development & Approvals: Successful clinical trials and FDA approvals for new drugs typically boost the stock price. Failures or delays can negatively impact it.

Sales Performance: Revenue generated from existing products and new launches directly influences profitability and investor confidence.

Patent Expiration & Competition: When patents expire, cheaper generics can enter the market, eroding market share and potentially lowering stock value. Increased competition from other pharmaceutical companies also poses a threat.

Legal & Regulatory Issues: Lawsuits, settlements related to product liability, or changes in healthcare regulations can significantly affect JNJ's financials and stock price.

Economic Conditions: Broad economic factors like inflation, interest rates, and overall market sentiment can influence investor behavior and impact stock valuations.

Mergers & Acquisitions: Strategic acquisitions or divestitures can create value or raise concerns, affecting stock prices accordingly.

Dividend Policy: Johnson & Johnson's dividend payments are a key attraction for investors. Changes in dividend policy can influence stock appeal.

Healthcare Policy Changes: Changes in healthcare laws and regulations, such as drug pricing reforms, can significantly impact JNJ's revenue and profitability.

Product Recalls: If products are found to have issues and are recalled, it can hurt the company's reputation and finances, negatively affecting the stock price.